RSS

CSL

Producer of tailor-made recombinant glycoproteins and gene therapy vectors, CEVEC Pharmaceuticals, and global biotechnology company, CSL, have announced an exclusive licensing agreement to produce a recombinant C1 Esterase Inhibitor. more

News

Seqirus, an influenza vaccine provider announced a £22.1m investment for its UK manufacturing site in Liverpool more

News